文献速递组学、生物样本库与精准医学基础与转化研究新药、器械与细胞基因治疗研发

细胞层级框架用于理解急性髓系白血病异质性并预测药物反应

A cellular hierarchy framework for understanding heterogeneity and predicting drug response in acute myeloid leukemia.
PubMed 文献 · Nat Med · 2022-05-26

研究通过对超过1000例急性髓系白血病(AML)患者 bulk 转录组进行去卷积,利用白血病干细胞、祖细胞和成熟细胞类型的单细胞参考谱确定白血病细胞层级构成,将其汇聚为原始型、成熟型、GMP型和中间型四类,层级构成变异与化疗反应或靶向药物敏感性相关,基于原始型与成熟型轴衍生的七基因生物标志物与105种在研药物反应相关。

要点

  • 白血病细胞层级构成可从 bulk 转录组去卷积获得,并汇聚为原始型、成熟型、GMP型和中间型四类。
  • 原始型与GMP轴变异与化疗反应相关,原始型与成熟轴变异与靶向药物敏感性谱相关。
  • 基于原始型与成熟轴衍生的七基因生物标志物与105种在研药物反应相关。

核心结论

  • 细胞层级构成构成理解AML疾病生物学和推进精准医学的新框架。

研究设计与样本

  • 利用白血病干细胞、祖细胞和成熟细胞类型的单细胞参考谱,对超过1000例患者的 bulk 转录组进行去卷积,确定白血病细胞层级构成。

主要发现

  • 白血病层级构成与功能、基因组和临床特征相关,并汇聚为原始型、成熟型、GMP型和中间型四类。
  • 层级构成沿原始型与GMP轴或原始型与成熟轴的变异分别与化疗反应或靶向药物敏感性谱相关。
  • 基于原始型与成熟轴衍生的七基因生物标志物与105种在研药物反应相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The treatment landscape of acute myeloid leukemia (AML) is evolving, with promising therapies entering clinical translation, yet patient responses remain heterogeneous, and biomarkers for tailoring treatment are lacking. To understand how disease heterogeneity links with therapy response, we determined the leukemia cell hierarchy makeup from bulk transcriptomes of more than 1,000 patients through deconvolution using single-cell reference profiles of leukemia stem, progenitor and mature cell types. Leukemia hierarchy composition was associated with functional, genomic and clinical properties and converged into four overall classes, spanning Primitive, Mature, GMP and Intermediate. Critically, variation in hierarchy composition along the Primitive versus GMP or Primitive versus Mature axes were associated with response to chemotherapy or drug sensitivity profiles of targeted therapies, respectively. A seven-gene biomarker derived from the Primitive versus Mature axis was associated with response to 105 investigational drugs. Cellular hierarchy composition constitutes a novel framework for understanding disease biology and advancing precision medicine in AML.

来源:Nat Med,查看原文。版权归原作者所有。

引用

  1. Zeng AGX, Bansal S, Jin L, et al. A cellular hierarchy framework for understanding heterogeneity and predicting drug response in acute myeloid leukemia. Nat Med. 2022. PMID: 35618837. doi:10.1038/s41591-022-01819-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。